{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T21:57:48Z","timestamp":1767650268330},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1007\/s00108-006-1750-4","type":"journal-article","created":{"date-parts":[[2006,12,19]],"date-time":"2006-12-19T14:00:19Z","timestamp":1166536819000},"page":"69-74","source":"Crossref","is-referenced-by-count":5,"title":["Angina Pectoris und ST-Hebungen nach Chemotherapie mit 5-FU"],"prefix":"10.1007","volume":"48","author":[{"given":"S.","family":"Spencker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Schmittel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Westermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Marek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. P.","family":"Schultheiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Witzenbichler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"1750_CR1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00392-005-0159-8","volume":"94","author":"Alter","year":"2005","unstructured":"Alter P, Herzum M, Schaefer JR et al. (2005) Coronary artery spasm induced by 5-fluorouracil. Z Kardiol 94: 33\u201337","journal-title":"Z Kardiol"},{"key":"1750_CR2","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1177\/106002809402800314","volume":"28","author":"Anand","year":"1994","unstructured":"Anand AJ (1994) Fluorouracil cardiotoxicity. Ann Pharmacother 28: 374\u2013378","journal-title":"Ann Pharmacother"},{"key":"1750_CR3","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2165\/00003495-199957040-00003","volume":"57","author":"Becker","year":"1999","unstructured":"Becker K, Erckenbrecht JF, Haussinger D et al. (1999) Cardiotoxicity of the antiproliferative compound fluorouracil. Drugs 57: 475\u2013484","journal-title":"Drugs"},{"key":"1750_CR4","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1200\/JCO.1992.10.11.1795","volume":"10","author":"Forni","year":"1992","unstructured":"Forni M de, Malet-Martino MC, Jaillais P et al. (1992) Cardiotoxicity of high-dose continuous infusion fluorouracil: a prospective clinical study. J Clin Oncol 10: 1795\u20131801","journal-title":"J Clin Oncol"},{"key":"1750_CR5","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/oxfordjournals.annonc.a057793","volume":"1","author":"Gradishar","year":"1990","unstructured":"Gradishar WJ, Vokes EE (1990) 5-Fluorouracil cardiotoxicity: a critical review. Ann Oncol 1: 409\u2013414","journal-title":"Ann Oncol"},{"key":"1750_CR6","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00280-005-0178-1","volume":"58","author":"Jensen","year":"2006","unstructured":"Jensen SA, Sorensen JB (2006) Risk factors and prevention of cardiotoxicity induced by 5-fluorouracil or capecitabine. Cancer Chemother Pharmacol 58: 487\u2013493","journal-title":"Cancer Chemother Pharmacol"},{"key":"1750_CR7","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/j.1552-4604.1993.tb01943.x","volume":"33","author":"Keefe","year":"1993","unstructured":"Keefe DL, Roistacher N, Pierri MK (1993) Clinical cardiotoxicity of 5-fluorouracil. J Clin Pharmacol 33: 1060\u20131070","journal-title":"J Clin Pharmacol"},{"key":"1750_CR8","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/0959-8049(95)00575-7","volume":"32A","author":"Lieutaud","year":"1996","unstructured":"Lieutaud T, Brain E, Golgran-Toledano D et al. (1996) 5-Fluorouracil cardiotoxicity: a unique mechanism for ischaemic cardiopathy and cardiac failure? Eur J Cancer 32A: 368\u2013369","journal-title":"Eur J Cancer"},{"key":"1750_CR9","first-page":"3028","volume":"53","author":"Mosseri","year":"1993","unstructured":"Mosseri M, Fingert HJ, Varticovski L et al. (1993) In vitro evidence that myocardial ischemia resulting from 5-fluorouracil chemotherapy is due to protein kinase C-mediated vasoconstriction of vascular smooth muscle. Cancer Res 53: 3028\u20133033","journal-title":"Cancer Res"},{"key":"1750_CR10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s00059-005-2648-y","volume":"30","author":"Schannwell","year":"2005","unstructured":"Schannwell CM, Steiner S, Strauer BE (2005) Hypertensive microvaskul\u00e4re Erkrankung. Herz 30: 26\u201336","journal-title":"Herz"},{"key":"1750_CR11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ctrv.2003.07.003","volume":"30","author":"Schimmel","year":"2004","unstructured":"Schimmel KJ, Richel DJ, van den Brink RB et al. (2004) Cardiotoxicity of cytotoxic drugs. Cancer Treat Rev 30: 181\u2013191","journal-title":"Cancer Treat Rev"},{"key":"1750_CR12","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1200\/JCO.1997.15.1.368","volume":"15","author":"Sobrero","year":"1997","unstructured":"Sobrero AF, Aschele C, Bertino JR (1997) Fluorouracil in colorectal cancer \u2013 a tale of two drugs: implications for biochemical modulation. J Clin Oncol 15: 368\u2013381","journal-title":"J Clin Oncol"},{"key":"1750_CR13","first-page":"PI51","volume":"8","author":"Tsavaris","year":"2002","unstructured":"Tsavaris N, Kosmas C, Vadiaka M et al. (2002) Cardiotoxicity following different doses and schedules of 5-fluorouracil administration for malignancy -- a survey of 427 patients. Med Sci Monit 8: PI51\u201357","journal-title":"Med Sci Monit"},{"key":"1750_CR14","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000072334","volume":"65","author":"Wacker","year":"2003","unstructured":"Wacker A, Lersch C, Scherpinski U et al. (2003) High incidence of angina pectoris in patients treated with 5-fluorouracil: a planned surveillance study with 102 patients. Oncology 65: 108\u2013112","journal-title":"Oncology"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-006-1750-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-006-1750-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-006-1750-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T04:11:38Z","timestamp":1558584698000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-006-1750-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["1750"],"URL":"https:\/\/doi.org\/10.1007\/s00108-006-1750-4","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}